z-logo
open-access-imgOpen Access
Effect of thiamine and thiamine levels on experimental alloxan induced diabetes mellitus.
Author(s) -
Reiko Hobara,
Hitoshi Kato,
Koji Sakamoto
Publication year - 1983
Publication title -
japanese journal of pharmacology/japanese journal of pharmacology
Language(s) - English
Resource type - Journals
eISSN - 1347-3506
pISSN - 0021-5198
DOI - 10.1254/jjp.33.27
Subject(s) - endocrinology , medicine , adipose tissue , kidney , diabetes mellitus , alloxan , thiamine , microgram , insulin , pancreas , chemistry , biochemistry , in vitro
The effects of thiamine (T) on diabetes mellitus (DM) and the T levels in the brain, heart, liver, kidneys pancreas, muscle, adipose tissue and blood were measured. For the experimental DM model, alloxan (170 mg/kg, i.v.) was injected into male ddY mice and insulin was also administered for 5 days to prevent death by hyperglycemia (DM group). After 14 days, blood glucose level increased to 455 mg/dl, compared to 166 mg/dl in the normal control group (NC group). In the DM mice, the T level in the liver decreased to 7.71 micrograms/g, compared to 16.29 micrograms/g in the NC group. The T levels in the heart, pancreas, muscle and adipose tissue increased to 18.63 micrograms/g, 3.99 micrograms/g, 2.53 micrograms/g and 5.07 micrograms/g in the DM group, compared to 14.99 micrograms/g, 3.27 micrograms/g, 1.98 micrograms/g and 4.04 micrograms/g in the NC group, respectively. The T levels in the brain and kidney were 2.38 micrograms/g and 14.00 micrograms/g in the DM group, compared to 2.34 micrograms/g and 13.72 micrograms/g in the NC group, respectively. But, in the heart, an active form of a T co-enzyme decreased to 27%, compared to 95% for the NC group. These results indicate a T deficiency or an endogenous T deficiency in the DM group. All DM mice without insulin treatment died within 7 days but about 40% of the mice survived up to 14 days with the administration of T.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here